News
ICUI
169.42
+2.50%
4.13
ICU Medical, Inc.'s (NASDAQ:ICUI) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
ICU Medical (NASDAQ:ICUI) has had a rough three months with its share price down 34%. However, stock prices are usually...
Simply Wall St. · 06/18 12:51
--CJS Securities Adjusts ICU Medical Price Target to $275 From $300, Maintains Market Outperform Rating
MT Newswires · 06/14 10:40
ICU Medical's Return On Capital Employed Insights
ICU Medical (NASDAQ:ICUI) brought in sales totaling $543.12 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 291.06%, resulting in a loss of $38.07 million.
Benzinga · 06/02 14:18
Insiders saw their US$4.5m investment bump up to US$4.6m after ICU Medical, Inc. (NASDAQ:ICUI) soared 3.3% last week
ICU Medical, Inc. ( NASDAQ:ICUI ) insiders who purchased shares in the last 12 months were richly rewarded last week...
Simply Wall St. · 05/19 12:05
Morgan Stanley And 2 Other Stocks Insiders Are Buying
Although US stocks closed sharply higher on Friday, there were a few notable insider trades.
Benzinga · 05/16 12:06
Insider Buy: Icu Medical
MT Newswires · 05/16 07:19
Raymond James Says 'Supply Chain Challenges Made Q1 Messy' For This Medtech Stock
Benzinga · 05/11 20:12
10 Biggest Price Target Changes For Tuesday
Keybanc cut PubMatic, Inc. (NASDAQ: PUBM) price target from $48 to $27. PubMatic shares fell 1.5% to $18.71 in pre-market trading.
Benzinga · 05/10 12:44
--Raymond James Lowers ICU Medical's Price Target to $235 From $265, Outperform Rating Kept
MT Newswires · 05/10 11:32
--KeyBanc Lowers ICU Medical's Price Target to $265 From $280, Overweight Rating Kept
MT Newswires · 05/10 10:57
ICU Medical (ICUI) Surpasses Q1 Earnings Estimates
ICU Medical (ICUI) delivered earnings and revenue surprises of 1.68% and 0.67%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 05/09 21:45
ICU Medical Q1 Adj. EPS $1.82 Beats $1.78 Estimate, Sales $543.10M Miss $553.17M Estimate
ICU Medical (NASDAQ:ICUI) reported quarterly earnings of $1.82 per share which beat the analyst consensus estimate of $1.78 by 2.25 percent. This is a 12.35 percent increase over earnings of $1.62 per share from the same
Benzinga · 05/09 21:04
ICU Medical Non-GAAP EPS of $1.82 beats by $0.04, revenue of $543.12M misses by $14.21M
ICU Medical press release (NASDAQ:ICUI): Q1 Non-GAAP EPS of $1.82 beats by $0.04. Revenue of $543.12M (+70.8% Y/Y) misses by $14.21M.
Seekingalpha · 05/09 20:23
-- Earnings Flash (ICUI) ICU MEDICAL Reports Q1 EPS $1.82, vs. Street Est of $1.78
MT Newswires · 05/09 16:57
The Week Ahead In Biotech (May 8-14): Bausch Health Headlines Smid-Cap Earnings, Veru's Pre-EUA Meeting, Conference Presentations And More
Biotech stocks declined yet again in the week ending May 6, dragged lower by macroeconomic concerns following the Federal Reserve's 50-basis-point rate hike. The iShares Biotechnology ETF (NASDAQ: IBB), considered a proxy for the sector, shed close to 3 pe...
Benzinga · 05/09 12:33
Net Asset Value(s)
LONDON, May 09, 2022-- FundsDate
Business Wire · 05/09 10:07
Earnings Scheduled For May 9, 2022
  Companies Reporting Before The Bell • Atlantica Sustainable (NASDAQ:AY) is likely to report quarterly loss at $0.08 per share on revenue of $277.90 million.
Benzinga · 05/09 08:52
Notable earnings after Monday's close
ADES, AGM, AIV, AKBA, ALCO, ALTO, AMC, AMPH, AMWL, ANGI, APPF, APTO, ARCT, AROC, ASLE, ASRT, ATER, AVIR, AZTA, BATL, BHF, BLFS, BLI, BLNK, BODY, OTCPK:BOWFF, BRMK, BRT, BW, BWXT,
Seekingalpha · 05/08 21:35
More
Webull provides a variety of real-time ICUI stock news. You can receive the latest news about Icu Medical through multiple platforms. This information may help you make smarter investment decisions.
About ICUI
ICU Medical, Inc. (ICU) is engaged in the development, manufacturing and sale of medical products used in infusion therapy and critical care applications. The Company provides infusion systems, infusion consumables and critical care products used in hospital, alternate site and home care settings. The Company's product portfolio includes IV solutions, IV smart pumps with pain management and safety software technology, dedicated and non-dedicated IV sets and needle free connectors. Its oncology products include ChemoLock and ChemoClave. Its IV consumables include Clave IV Connector Technology, IV Sets, Peripheral IV Catheters and Disinfecting Caps. Its primary critical care products include Cogent, CardioFlo, TDQ and OptiQ, TriOx, Transpac and SafeSet. Its IV Solutions products include IV Therapy and Diluents, and Irrigation. Its Infusion System products include Infusion Pump Hardware, IV Mediation Safety Software and Professional Services. It offers blood pressure monitoring system.